Streetbeat News

Price Targets

EVTC

Raymond James analyst John Davis has maintained an Outperform rating on Evertec (NYSE:EVTC) and raised the price target from $43 to $49.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 8:34 am

CMA

Raymond James analyst Michael Rose has maintained a 'Strong Buy' rating on Comerica (NYSE:CMA) and raised the price target from $53 to $57.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 8:33 am

SNA

Barrington Research analyst Gary Prestopino has reiterated an Outperform rating on Snap-on (NYSE:SNA) and maintained a price target of $325.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 8:29 am

WMS

Keybanc analyst Jeffrey Hammond has initiated coverage on Advanced Drainage Systems (NYSE:WMS) with an Overweight rating and a price target of $150.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 8:26 am

PPG

Keybanc analyst Aleksey Yefremov maintains an Overweight rating on PPG Indus (NYSE:PPG) and raises the price target from $171 to $172.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 8:24 am

ABNB

Keybanc analyst Justin Patterson maintains an Overweight rating on Airbnb (NASDAQ:ABNB) and raises the price target from $135 to $160.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 8:23 am

RBC

In the last quarter, RBC Bearings (NYSE:RBC) has received 3 bullish and 1 somewhat bullish ratings from analysts. The company has an average 12-month price target of $266.5, with a high of $286.00 and a low of $252.00. The average price target has increased by 0.76% over the past month.

Portfolio Pulse from Benzinga Insights

July 21, 2023 | 9:00 pm

VST

Morgan Stanley has maintained an Overweight rating on Vistra's stock and increased its price target from $32 to $33. This has led to a rise in Vistra's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 7:31 pm

LFMD

Cantor Fitzgerald initiated coverage on LifeMD Inc (NASDAQ:LFMD) with an Overweight rating and a price target of $7, almost double the current price. The analyst sees LifeMD as an undervalued growth story in the virtual primary-care sector, expecting the company's topline to grow in the 20-30% CAGR range over the next 3-5 years. LifeMD's weight-management virtual clinic is seen as a key growth driver, with potential to tap into the $100-200B weight-loss medication market.

Portfolio Pulse from Vandana Singh

July 21, 2023 | 7:01 pm

SO

Over the past 3 months, 8 analysts have published their opinion on Southern (NYSE:SO) stock. The company has an average price target of $69.62, an increase of 1.74% from the previous average price target of $68.43. The analysts' ratings are mixed, with 2 bullish, 2 indifferent, and 4 somewhat bearish.

Portfolio Pulse from Benzinga Insights

July 21, 2023 | 7:00 pm